Presenter: Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk
In episode 584, Mike and James invite Tina Korownyk back to the podcast to talk about the evidence for amyloid-targeting monoclonal antibodies in mild cognitive impairment or Alzheimer’s dementia. Unfortunately, the evidence shows these medications don’t seem to have a clinically important effect and do have some harms. Have a listen as we give you…
Latest Podcasts
In the Clinic Episode #33: Smoking Cessation
In this episode of In the Clinic, Mike and Jess invite back Dr. Émélie Braschi. The team discusses Xiao Yun, a 68-year old male patient who is trying to quit smoking To earn…
In the Clinic Episode #32: Pediatric Asthma
In this episode of In the Clinic, Mike and Jess invite back Dr. Jennifer Young. The team discusses Brea Salter, a 4-year old girl presenting with wheezing. To earn an additional 0.25…
BS Medicine Episode #592: Pharm for Fibro: Can antidepressants ease the pain?
In episode 592, Mike and James invite Jennifer Young back to the podcast to review the evidence around the use of antidepressants in the challenging pain condition of fibromyalgia. We…
September 19, 2024
Presenter(s):
Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk
Please provide any additional comments (optional).